These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 24258971)
1. Emerging clinical issues in melanoma in the molecularly targeted era. Sullivan RJ; Atkins MB Methods Mol Biol; 2014; 1102():11-26. PubMed ID: 24258971 [TBL] [Abstract][Full Text] [Related]
2. Integrating molecular biomarkers into current clinical management in melanoma. Kudchadkar R; Gibney G; Sondak VK Methods Mol Biol; 2014; 1102():27-42. PubMed ID: 24258972 [TBL] [Abstract][Full Text] [Related]
3. Metastatic melanoma: the new era of targeted therapy. Guida M; Pisconti S; Colucci G Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S61-70. PubMed ID: 22443134 [TBL] [Abstract][Full Text] [Related]
4. Novel insights/translational implication from the emerging biology of melanoma. Ribas A Methods Mol Biol; 2014; 1102():3-9. PubMed ID: 24258970 [TBL] [Abstract][Full Text] [Related]
5. Current therapy of cutaneous melanoma. Mays SR; Nelson BR Cutis; 1999 May; 63(5):293-8. PubMed ID: 10349545 [TBL] [Abstract][Full Text] [Related]
6. Systemic treatment of malignant melanoma: grade is as important as stage. Retsas S Clin Exp Dermatol; 1997 Mar; 22(2):67-71. PubMed ID: 9330068 [TBL] [Abstract][Full Text] [Related]
7. Oncogenetics of melanoma: basis for molecular diagnostics and therapy. Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632 [TBL] [Abstract][Full Text] [Related]
13. New therapeutic options in the medical management of advanced melanoma. Lutzky J Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538 [TBL] [Abstract][Full Text] [Related]
14. New therapeutical strategies in the treatment of metastatic disease. Julia F; Thomas L; Dalle S Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024 [TBL] [Abstract][Full Text] [Related]
15. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Lo JA; Fisher DE Science; 2014 Nov; 346(6212):945-9. PubMed ID: 25414302 [TBL] [Abstract][Full Text] [Related]
17. Successes and limitations of targeted cancer therapy in melanoma. Romano E; Michielin O Prog Tumor Res; 2014; 41():78-88. PubMed ID: 24727988 [TBL] [Abstract][Full Text] [Related]
18. Medical management of melanoma. Brown CK; Kirkwood JM Surg Clin North Am; 2003 Apr; 83(2):283-322, viii. PubMed ID: 12744611 [TBL] [Abstract][Full Text] [Related]
19. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence. Kimyai-Asadi A; Usman A J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636 [TBL] [Abstract][Full Text] [Related]
20. Current and planned multicenter trials for patients with primary or metastatic melanoma. Sondak VK; Han D; Deneve J; Kudchadkar R J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]